Sunday November 8 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Optic Nerve Glioma

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Optic Nerve Glioma:

Pubmed Logo
Multiple wedge-shaped retinal nerve fiber layer defects in a patient with optic nerve glioma in the contralateral eye: case report.
This case report describes a young non-glaucomatous patient with...
13th October, 2009
Department of Ophthalmology, Universidade Federal de Sao Paulo, Sao Paulo, Arq Bras Oftalmol. 2009 Jul-Aug;72(4):556-9.
Neurofibromatosis type 1.
Neurofibromatosis type 1 (NF1) is an autosomal dominant, multisystem...
25th September, 2009
Departments of Dermatology and Genetics, University of Alabama at J Am Acad Dermatol. 2009 Jul;61(1):1-14; quiz 15-6.
DOI Direct Link
Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma.
Individuals with neurofibromatosis type 1 (NF1) are prone to develop optic...
11th September, 2009
Department of Neurology, Washington University School of Medicine, St J Neuropathol Exp Neurol. 2009 May;68(5):542-51.
DOI Direct Link
Optic-pathway glioma: natural history demonstrated by a new empirical score.
The optic pathway glioma uniquely involves the optic pathway in a...
11th August, 2009
Department of Pediatric Neurology, Schneider Children's Medical Center of Pediatr Neurol. 2009 Jun;40(6):432-6.
DOI Direct Link
Three-dimensional ultrasound of ophthalmic pathologies.
PURPOSE: To assess three-dimensional echography image quality and...
7th August, 2009
Eye Department, University Ophthalmologica. 2009;223(3):183-7. Epub 2009 Jan 31.
DOI Direct Link

View more research publications.

Press Releases About Optic Nerve Glioma:

BioPortfolio Logo
Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 6th November, 2009 Cyberonics, Inc.
HOUSTON, Nov. 6 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that the company will report financial results for the second quarter ended October 23, 2009 of its fiscal
Regeneron Reports Third Quarter 2009 Financial and Operating Results 3rd November, 2009 Regeneron Pharmaceuticals, Inc.
TARRYTOWN, N.Y., Nov. 3 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced financial and operating results for the third quarter of 2009. The Company reported a
Cyberonics Announces Epilepsy Technology Collaboration 2nd November, 2009 Cyberonics, Inc.
HOUSTON, Nov. 2 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced another in a series of collaborations around seizure detection technology aimed at advancing its development
NexGenix Pharmaceuticals Awarded Phase I Grant from the National Institute of Neurological Disorders and Stroke (NINDS) Small Business Innovation Research Program (SBIR) for the Development of Novel Small Molecule Hsp90 Therapeutics to Treat Glioma 22nd October, 2009 NexGenix Pharmaceuticals Holdings, Inc.
NEW YORK, Oct. 22 /PRNewswire/ -- NexGenix Pharmaceuticals Holdings, Inc. a privately-held biotechnology company with a portfolio of novel targeted therapies for oncology and neurodegenerative
Sangamo BioSciences Announces Presentation of Top-Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeting 20th October, 2009 Sangamo BioSciences, Inc.
-- "Epidermal nerve fiber density and regeneration with vascular endothelial growth factor zinc finger protein activator (SB-509) in mild to moderate diabetic peripheral

Optic Nerve Glioma Clinical Trials:

Clinical Trials Logo
Natural History Study of Patients With Neurofibromatosis Type I

Optic Nerve Glioma Patents:

USPTO Logo
US Patent No.Title
7479481 Treatment of ocular diseases and disorders using lantibiotic compositions
6537301 Method of noninvasively enhancing immunosurveillance capacity and apparatus for applying pulsed light to at least forehead
6129748 Apparatus for applying pulsed light to the forehead of a user
5769878 Method of noninvasively enhancing immunosurveillance capacity

BioPortfolio Ltd. offers e-mail and postal lists for Optic Nerve Glioma scientists - we have details of around 27 individuals working on Optic Nerve Glioma .


This page has been viewed 438 times
Recent Search Terms used to find this page: Optic Nerve Glioma | neurofibromatosis optic nerve 2009 | medical trials optic nerve glioma | glioma pdf | baltimore optic nerve glioma | gliomas.pdf | optic chiasm glioma research | optic chiasmatic glioma | tumour on optic nerve | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Optic Nerve Glioma across BioPortfolio, or for Optic Nerve Glioma Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.